>>MSCI – Two additions to MSCI Indonesia: Charoen Pokphand Indonesia (CPIN) and Kalbe Farma (KLBF). Estimated buying volume for CPIN is 43.5mn shares, for KLBF is 133mn shares.>>>
"إِنَّا مَكَّنَّا لَهُۥ فِى ٱلْأَرْضِ وَءَاتَيْنَهُ مِن كُلِّ شَىْءٍۢ سَبَبًۭا فَأَتْبَعَ سَبَبًا Sesungguhnya Kami telah memberi kekuasaan kepadanya di (muka) bumi, dan Kami telah memberikan kepadanya jalan (untuk mencapai) segala sesuatu, maka diapun menempuh suatu jalan." (QS. AL KAHFI:84-85)
>> Saham Agung Podomoro Dilepas Rp365 per Unit >>> INDY: After mkt close the major shareholders placed out a USD 200m block of stock, or about 10% of cap at 3675 (range 3600-3725) at a 5.7% discount. The placement was said to be 3X subscribed to.

My Family

Selasa, 10 Februari 2009

Macquarie Bumi Resources (Underperform) - Will the regulator save minorities?

Event
Bapepam, Indonesia's capital markets regulator, has just made a presentation to the Indonesian parliament (House of Representatives) regarding recent events in the capital markets, including the Bumi's latest transactions. It appears Bapepam is considering grouping all of Bumi's three transactions, which could lead to minority approval being required.

Impact
Political pressure on Bakrie and Bapepam. It is clear that political pressure is growing on Bapepam and Bakrie/Bumi to justify recent transactions or events. Bapepam, in particular, is under scrutiny by the parliament following the Bumi transactions, Sarijaya (local securities company) and Bank Century fraud, and the Merrill Lynch lawsuit.
We welcome the regulator insisting on minority approval as we believe the transactions were undertaken at a premium to market prices with questionable links to related parties. Further, this could potentially reduce the risk of similar transactions going forward should this minority approval be implemented.
Grouping three transactions as one? We do not understand why the regulator would group three transactions into one, as they appear separate to us. The regulator appears to be under pressure to retract their previous comments.
Can a leopard (Bumi/Bakrie) change its spots? We do not think so. Even if Bapepam were able to insist on a minority approval, we think this would be disputed in the Indonesian law courts. Further, Bumi has shown its intention to circumvent minority shareholder approval, and therefore we highlight the risk of subsidiaries KPC's and Arutmin's FCF still not returning to minority shareholders via dividends.

Action and recommendation
We reiterate our Underperform recommendation and Rp500 price target. While we recognise the strong valuation argument (note that it could be a speculative trade), we do not think this is an investment grade company as we highlight the potential for other related party transactions, which could lead to a deterioration of Bumi's future free cashflow (FCF).

Tidak ada komentar:

Posting Komentar

Yahoo! Finance: Top Stories

Reuters: Business News

Insider Stories

CNBC Top News and Analysis

» Ekobiz

The Wall Street Journal

AnggunTraders.com

Commodity Online Metals News

Britama.com

Palm Oil Prices

Commodities-Markets-The Economic Times

Detikfinance

BusinessWeek.com -- Top News

Palm Oil HQ Daily Update

Business Times : marketwatch

VIVAnews - BISNIS

The Star Online: Business

Inilah.com -

Latest financial news - CNNMoney.com

Tempointeraktif.com - Bisnis

ChinaDaily > bizchina

Sindikasi economy.okezone.com

Commodity News

Bursa Rumor - Tempatnya Investor Saham Cari Berita

Financial Times - Financial markets news

Hellenic Shipping News

ANTARA - Ekonomi & Bisnis

Industrial Metals & Minerals Industry News

Republika Online - Ekonomi

Yahoo Commodities News